Skip to content

Young Adult Hypertension Self-Management Clinical Trial

The MyHEART Study: A Young Adult Hypertension Self-Management Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03158051
Acronym
MyHEART
Enrollment
316
Registered
2017-05-17
Start date
2017-10-02
Completion date
2022-02-08
Last updated
2023-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension, Blood Pressure, Lifestyle Risk Reduction

Keywords

Hypertension, Young Adult, Self-Management, Health coach

Brief summary

This is a 5-year randomized controlled trial in two large healthcare systems (Madison and Milwaukee, WI) to evaluate MyHEART's (My Hypertension Education And Reaching Target) impact on blood pressure among 310 geographically and racially/ethnically diverse young adults.

Detailed description

Aim 1. To evaluate the effect of MyHEART (home blood pressure monitor distribution and heath coaching) on clinical outcomes, the change in systolic and diastolic blood pressure (primary) and hypertension control (secondary) after 6 and 12 months, compared to usual clinical care. Aim 2. To evaluate the effect of MyHEART on hypertension self-management behavior (behavioral outcomes) at 6 and 12 months, compared to usual clinical care. Aim 3. To examine whether MyHEART's effects on self-management behavior are mediated through variables of perceived competence, autonomy, motivation, and activation (mediation outcomes).

Interventions

Intervention arm participants will receive a home blood pressure monitor, home blood pressure log, and training on accurate home monitoring. They will be asked to share their home blood pressure readings during health coach telephone calls.

Intervention arm participants will receive a health coach phone call every 2 weeks for 6 months, for a total of 12 calls. During each call, the health coach will review and discuss home blood pressures and address barriers and concerns to hypertension management. During each telephone call, the coach will guide the participant on selecting health behavior goals. Intervention arm participants will also receive handouts about hypertension management during the study visits and after health coach calls.

Sponsors

National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
Wake Forest University Health Sciences
CollaboratorOTHER
University of Wisconsin, Madison
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 39 Years
Healthy volunteers
No

Inclusion criteria

* Willing and capable of giving written informed consent * Willing to comply with all study procedures and be available for the duration of the study * Males and females ages 18-39 years old at the start of the study (inclusive) * A minimum of two hypertension ICD-10 coded visits with a provider (physician \[MD, DO\], physician assistant, nurse practitioner) on different dates in the last 24 months, with at least one code in the past 18 months * Medically homed at an IRB approved healthcare system

Exclusion criteria

* History of medically determined Congestive Heart Failure * Unable to provide informed consent (i.e., activated healthcare power of attorney) * Unable or unwilling to travel to local clinic for research visits * Currently residing in a skilled nursing facility * Diagnosed with sickle cell anemia or cystic fibrosis * Diagnosed with stroke, myocardial infarction, and/or coronary artery revascularization in the past 2 years * Syncope while exercising or doing strenuous activity within past 12 months * Currently prescribed warfarin, novel oral anticoagulant, or insulin * Planned organ transplant or prior transplant in the past 5 years * Chemotherapy or radiation therapy within 6 the past months * Severely impaired hearing, vision, or speech, as determined by study staff responsible for enrollment * Current participation or planning to participate in another clinical trial in the next 12 months * Pregnant or planning to become pregnant in the next 12 months * Planning to leave the geographic area in the next 6 months * Health condition that will limit both increasing physical activity and changing diet * Illegal drug use (other than marijuana) in the past 30 days * Unable to read or communicate in English * Currently on dialysis or seeing a Nephrologist * Unaware or denies history of high blood pressure or hypertension * Between-arm blood pressure difference \>20 mmHg * White Coat Hypertension (24-hour ambulatory monitoring) * Inability to comply with or complete the protocol or other reasons at the discretion of the principal and site investigators * Prisoners

Design outcomes

Primary

MeasureTime frameDescription
Clinic Diastolic Blood Pressure (mmHg)baseline, 6 month, and 12 month follow-upClinic Diastolic Blood Pressure measured at baseline, 6 months, and 12 months.
Clinic Systolic Blood Pressure (mmHg)baseline, 6 month, and 12 month follow-upSystolic Blood Pressure measured at baseline, 6 months, and 12 months.
24-hour Diastolic Ambulatory Blood Pressure (mmHg)baseline, 6 month, and 12 month follow-up24-hour Diastolic Ambulatory Blood Pressure measured at baseline, 6 months, and 12 months.
24-hour Systolic Ambulatory Blood Pressure (mmHg)baseline, 6 month, and 12 month follow-up24-hour Systolic Ambulatory Blood Pressure measured at baseline, 6 months, and 12 months.

Secondary

MeasureTime frameDescription
Ounces of Whole Grain as Assessed by the Automated Self-Administered 24-hour Dietary Assessmentbaseline, 6 month, and 12 month follow-upOunces of whole grain measured at baseline, 6 months, and 12 months as assessed by the computer administered Automated Self-Administered 24-hour Dietary Assessment
Saturated Fat as Assessed by the Automated Self-Administered 24-hour Dietary Assessmentbaseline, 6 month, and 12 month follow-upSaturated fat measured at baseline, 6 months, and 12 months as assessed by the computer administered Automated Self-Administered 24-hour Dietary Assessment, reported in percent kilocalories
Physical Activity as Assessed by the Godin Physical Activity Questionnairebaseline, 6 month, and 12 month follow-upMean weekly amounts of physical activity as assessed by the Godin Physical Activity Questionnaire. The Godin Physical Activity Questionnaire measures a person's strenuous, moderate, and light physical activity in a week. Scoring is calculated as follows (units are times per week that the participant engaged in any of the 3 classifications of activity longer than 15 minutes during their free time): * 9 x strenous units reported + 5 x moderate units reported + 3 x light units reported = score A minimum score of 0 indicates no activity, a score of less than 14 is interpreted as insufficiently active or sedentary, a score between 14 and 23 is interpreted to be moderately active, and a score of 24 and higher is interpreted to be active, a theoretical maximum does not exist.
Home Blood Pressure Monitoring Frequencybaseline, 6 month, and 12 month follow-upSelf-report of home blood pressure monitoring frequency measured at baseline, 6 months, and 12 months.
Standing Weight (kg)baseline, 6 month, and 12 month follow-upWeight (kg) measured at baseline, 6 months, and 12 months.
Perceived Competence as Assessed by the Perceived Competence Scale for Dietbaseline, 6 month, and 12 month follow-upPerceived competence measured at baseline, 6 months, and 12 months as assessed by the Perceived Competence Scale (self-administration). This is a 4-item survey scored on a 7 point likert scale from 1 (not at all true) to 7 (very true). Mean score from 1-7 will be reported with higher scores indicating increased perceived competence.
Perceived Autonomy as Assessed by the Health Care Climate Questionnaire for Dietbaseline, 6 month, and 12 month follow-upPerceived autonomy measured at baseline, 6 months, and 12 months as assessed by the Health Care Climate Questionnaire (self-administration). This is a 6-item survey scored on a 7 point likert scale from 1 (not at all true) to 7 (very true). Mean between 1-7 will be reported with higher scores indicative of increased perceived autonomy.
Perceived Autonomy as Assessed by the Health Care Climate Questionnaire for Exercisebaseline, 6 month, and 12 month follow-upPerceived autonomy measured at baseline, 6 months, and 12 months as assessed by the Health Care Climate Questionnaire (self-administration). This is a 6-item survey scored on a 7 point likert scale from 1 (not at all true) to 7 (very true). Mean between 1-7 will be reported with higher scores indicative of increased perceived autonomy.
Autonomous Motivation as Assessed by the Treatment Self-Regulation Questionnaire for Dietbaseline, 6 month, and 12 month follow-upAutonomous motivation measured at baseline, 6 months, and 12 months as assessed by the Treatment Self-Regulation Questionnaire (self-administration). This is a 15-item survey scored on a 7 point likert scale from 1 (not at all true) to 7 (very true). Mean score between 1 and 7 will be reported with higher scores indicative of increased autonomous motivation.
Autonomous Motivation as Assessed by the Treatment Self-Regulation Questionnaire for Exercisebaseline, 6 month, and 12 month follow-upAutonomous motivation measured at baseline, 6 months, and 12 months as assessed by the Treatment Self-Regulation Questionnaire (self-administration). This is a 15-item survey scored on a 7 point likert scale from 1 (not at all true) to 7 (very true). Mean score between 1 and 7 will be reported with higher scores indicative of increased autonomous motivation.
Controlled Motivation as Assessed by the Treatment Self-Regulation Questionnaire for Dietbaseline, 6 month, and 12 month follow-upControlled motivation measured at baseline, 6 months, and 12 months as assessed by the Treatment Self-Regulation Questionnaire (self-administration). This is a 15-item survey scored on a 7 point likert scale from 1 (not at all true) to 7 (very true). Mean score between 1 and 7 will be reported with higher scores indicative of increased controlled motivation.
Controlled Motivation as Assessed by the Treatment Self-Regulation Questionnaire for Exercisebaseline, 6 month, and 12 month follow-upControlled motivation measured at baseline, 6 months, and 12 months as assessed by the Treatment Self-Regulation Questionnaire (self-administration). This is a 15-item survey scored on a 7 point likert scale from 1 (not at all true) to 7 (very true). Mean score between 1 and 7 will be reported with higher scores indicative of increased controlled motivation.
Amotivation as Assessed by the Treatment Self-Regulation Questionnaire for Dietbaseline, 6 month, and 12 month follow-upAmotivation measured at baseline, 6 months, and 12 months as assessed by the Treatment Self-Regulation Questionnaire (self-administration). This is a 15-item survey scored on a 7 point likert scale from 1 (not at all true) to 7 (very true). Mean score between 1 and 7 will be reported with higher scores indicative of increased amotivation.
Amotivation as Assessed by the Treatment Self-Regulation Questionnaire for Exercisebaseline, 6 month, and 12 month follow-upAmotivation measured at baseline, 6 months, and 12 months as assessed by the Treatment Self-Regulation Questionnaire (self-administration). This is a 15-item survey scored on a 7 point likert scale from 1 (not at all true) to 7 (very true). Mean score between 1 and 7 will be reported with higher scores indicative of increased amotivation.
Perceived Competence as Assessed by the Perceived Competence Scale for Exercisebaseline, 6 month, and 12 month follow-upPerceived competence measured at baseline, 6 months, and 12 months as assessed by the Perceived Competence Scale (self-administration). This is a 4-item survey scored on a 7 point likert scale from 1 (not at all true) to 7 (very true). Mean score from 1-7 will be reported with higher scores indicating increased perceived competence.
Number of Participants That Achieve Hypertension Control at 6 Monthsup to 6 monthsHypertension Control: Percentage of participants that achieve hypertension control at 6 months. Hypertension control will be defined using ambulatory blood pressures as the gold standard (\<130/80 mmHg); otherwise a clinic blood pressure of \<140/90 mmHg will be used.
Sodium Intake as Assessed by the Automated Self-Administered 24-hour Dietary Assessmentbaseline, 6 month, and 12 month follow-upMean daily sodium intake (milligrams/day) at baseline, 6 months, and 12 months as assessed by the computer administered Automated Self-Administered 24-hour Dietary Assessment
Number of Combined Fruit and Vegetable Servings as Assessed by the Automated Self-Administered 24-hour Dietary Assessmentbaseline, 6 month, and 12 month follow-upMean number of combined fruit and vegetable servings measured at baseline, 6 months, and 12 months as assessed by the computer administered Automated Self-Administered 24-hour Dietary Assessment, reported in cups equivalent.

Other

MeasureTime frameDescription
Health Coach Fidelity to the Study Interventionthrough completion of administering the study intervention, an average of 4 yearsEvaluation of health coach fidelity to administering the motivational interviewing intervention per protocol will be assessed every 2 months using a modified Behavior Change Counseling Index
WithdrawalThrough study completion, an average of 5 yearsSubject Withdrawal Rate
Serious Adverse EventsThrough study completion, an average of 5 yearsNumber and type of serious adverse events
Adverse EventsThrough study completion, an average of 5 yearsNumber and type of adverse events

Countries

United States

Participant flow

Participants by arm

ArmCount
Intervention
Telephone health coaching, home blood pressure monitoring, individualized goal setting, and tailored educational materials.
157
Usual Clinical Care
Usual care arm participants will receive routine hypertension clinical care per their primary care provider.
159
Total316

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyDeath01
Overall StudyLost to Follow-up4147
Overall StudyPhysician Decision67
Overall StudyWithdrawal by Subject2415

Baseline characteristics

CharacteristicUsual Clinical CareTotalIntervention
Age, Continuous33.7 years33.8 years33.8 years
Alcohol Beverages per week5.1 servings of alcohol per week5.2 servings of alcohol per week5.3 servings of alcohol per week
Ambulatory Diastolic Blood Pressure (BP)87.0 mmHg86.7 mmHg86.5 mmHg
Ambulatory Systolic BP133.0 mmHg132.8 mmHg132.6 mmHg
Body Mass Index (BMI)34.5 kg/m^234.5 kg/m^234.5 kg/m^2
Cigarette Tobacco Status
Currently Smoke Cigarettes
19 Participants40 Participants21 Participants
Cigarette Tobacco Status
Have Never Smoked Cigarettes
115 Participants212 Participants97 Participants
Cigarette Tobacco Status
Unknown
0 Participants5 Participants5 Participants
Cigarette Tobacco Status
Used to Smoke Cigarettes
25 Participants59 Participants34 Participants
Comorbidities
Anxiety and / or Depression
78 Participants160 Participants82 Participants
Comorbidities
Chronic Kidney Disease
2 Participants3 Participants1 Participants
Comorbidities
Diabetes
9 Participants18 Participants9 Participants
Comorbidities
Dyslipidemia
32 Participants73 Participants41 Participants
Comorbidities
Other Chronic Comorbidity
59 Participants121 Participants62 Participants
Godin-Shephard Physical Activity
Active
81 Participants149 Participants68 Participants
Godin-Shephard Physical Activity
Insufficiently Active
78 Participants162 Participants84 Participants
Godin-Shephard Physical Activity
Unknown
0 Participants5 Participants5 Participants
Highest Level of Education
I have completed High School
20 Participants42 Participants22 Participants
Highest Level of Education
I have finished College or Vocational School
74 Participants137 Participants63 Participants
Highest Level of Education
I have not finished College or Vocational School
24 Participants52 Participants28 Participants
Highest Level of Education
I have not finished High School
8 Participants15 Participants7 Participants
Highest Level of Education
Some / Completed Graduate of Professional School
33 Participants65 Participants32 Participants
Highest Level of Education
Unknown
0 Participants5 Participants5 Participants
Marital Status
Divorced / Widower
4 Participants7 Participants3 Participants
Marital Status
Married / Partnered
101 Participants200 Participants99 Participants
Marital Status
Single
54 Participants104 Participants50 Participants
Marital Status
Unknown
0 Participants5 Participants5 Participants
Number of Antihypertensive Medications
0
78 Participants162 Participants84 Participants
Number of Antihypertensive Medications
1
51 Participants97 Participants46 Participants
Number of Antihypertensive Medications
2
21 Participants43 Participants22 Participants
Number of Antihypertensive Medications
3
8 Participants11 Participants3 Participants
Number of Antihypertensive Medications
greater than or equal to 4
1 Participants3 Participants2 Participants
Number of Children at Home1.0 children1.0 children1.1 children
Office Diastolic BP91.8 mmHg91.3 mmHg90.8 mmHg
Office Systolic BP138.0 mmHg138.1 mmHg138.3 mmHg
Race/Ethnicity, Customized
Black
35 Participants72 Participants37 Participants
Race/Ethnicity, Customized
Other
9 Participants22 Participants13 Participants
Race/Ethnicity, Customized
White
115 Participants222 Participants107 Participants
Region of Enrollment
United States
159 participants316 participants157 participants
Risk Factors
E-Cigarette / Vaping Use in the past 6 months
13 Participants26 Participants13 Participants
Risk Factors
Ever Been on Medicaid
33 Participants67 Participants34 Participants
Risk Factors
Family History of Heart Disease or Stroke
61 Participants113 Participants52 Participants
Risk Factors
Financial Status: Inadequate Income
122 Participants248 Participants126 Participants
Self-Perceived Health Status
Excellent
4 Participants7 Participants3 Participants
Self-Perceived Health Status
Fair
50 Participants111 Participants61 Participants
Self-Perceived Health Status
Poor or No Response
21 Participants39 Participants18 Participants
Self-Perceived Health Status
Unknown
1 Participants6 Participants5 Participants
Self-Perceived Health Status
Very Good or Good
83 Participants153 Participants70 Participants
Sex/Gender, Customized
Female
74 Participants145 Participants71 Participants
Sex/Gender, Customized
Male
85 Participants166 Participants81 Participants
Sex/Gender, Customized
Unknown
0 Participants5 Participants5 Participants
Waist Circumference109.4 centimeters109.4 centimeters109.5 centimeters
Weight103.3 kilograms103.2 kilograms103.1 kilograms

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 1571 / 159
other
Total, other adverse events
56 / 15738 / 159
serious
Total, serious adverse events
3 / 1575 / 159

Outcome results

Primary

24-hour Diastolic Ambulatory Blood Pressure (mmHg)

24-hour Diastolic Ambulatory Blood Pressure measured at baseline, 6 months, and 12 months.

Time frame: baseline, 6 month, and 12 month follow-up

Population: participants lost to follow up, withdrew, and/or removed from study per physician

ArmMeasureGroupValue (MEAN)Dispersion
Intervention24-hour Diastolic Ambulatory Blood Pressure (mmHg)baseline86.45 mmHgStandard Deviation 7.76
Intervention24-hour Diastolic Ambulatory Blood Pressure (mmHg)6 months84.61 mmHgStandard Deviation 8.24
Intervention24-hour Diastolic Ambulatory Blood Pressure (mmHg)12 months85.34 mmHgStandard Deviation 9.32
Usual Clinical Care24-hour Diastolic Ambulatory Blood Pressure (mmHg)baseline87.04 mmHgStandard Deviation 8.16
Usual Clinical Care24-hour Diastolic Ambulatory Blood Pressure (mmHg)6 months85.89 mmHgStandard Deviation 9.19
Usual Clinical Care24-hour Diastolic Ambulatory Blood Pressure (mmHg)12 months85.52 mmHgStandard Deviation 9.43
Primary

24-hour Systolic Ambulatory Blood Pressure (mmHg)

24-hour Systolic Ambulatory Blood Pressure measured at baseline, 6 months, and 12 months.

Time frame: baseline, 6 month, and 12 month follow-up

Population: participants lost to follow up, withdrew, and/or removed from study per physician

ArmMeasureGroupValue (MEDIAN)Dispersion
Intervention24-hour Systolic Ambulatory Blood Pressure (mmHg)baseline132.59 mmHgStandard Deviation 11.36
Intervention24-hour Systolic Ambulatory Blood Pressure (mmHg)6 month128.14 mmHgStandard Deviation 11.36
Intervention24-hour Systolic Ambulatory Blood Pressure (mmHg)12 month128.54 mmHgStandard Deviation 11.95
Usual Clinical Care24-hour Systolic Ambulatory Blood Pressure (mmHg)baseline133.01 mmHgStandard Deviation 12.67
Usual Clinical Care24-hour Systolic Ambulatory Blood Pressure (mmHg)6 month130.69 mmHgStandard Deviation 13.99
Usual Clinical Care24-hour Systolic Ambulatory Blood Pressure (mmHg)12 month129.47 mmHgStandard Deviation 14.71
Primary

Clinic Diastolic Blood Pressure (mmHg)

Clinic Diastolic Blood Pressure measured at baseline, 6 months, and 12 months.

Time frame: baseline, 6 month, and 12 month follow-up

Population: participants lost to follow up, withdrew, and/or removed from study per physician

ArmMeasureGroupValue (MEAN)Dispersion
InterventionClinic Diastolic Blood Pressure (mmHg)baseline90.81 mmHgStandard Deviation 11.42
InterventionClinic Diastolic Blood Pressure (mmHg)6 months83.83 mmHgStandard Deviation 9.36
InterventionClinic Diastolic Blood Pressure (mmHg)12 months85.05 mmHgStandard Deviation 10.56
Usual Clinical CareClinic Diastolic Blood Pressure (mmHg)baseline91.77 mmHgStandard Deviation 11.26
Usual Clinical CareClinic Diastolic Blood Pressure (mmHg)6 months86.70 mmHgStandard Deviation 12.44
Usual Clinical CareClinic Diastolic Blood Pressure (mmHg)12 months85.15 mmHgStandard Deviation 12.31
Primary

Clinic Systolic Blood Pressure (mmHg)

Systolic Blood Pressure measured at baseline, 6 months, and 12 months.

Time frame: baseline, 6 month, and 12 month follow-up

Population: participants lost to follow up, withdrew, and/or removed from study per physician

ArmMeasureGroupValue (MEDIAN)Dispersion
InterventionClinic Systolic Blood Pressure (mmHg)baseline138.30 mmHgStandard Deviation 14.27
InterventionClinic Systolic Blood Pressure (mmHg)6 month130.84 mmHgStandard Deviation 12.16
InterventionClinic Systolic Blood Pressure (mmHg)12 month131.16 mmHgStandard Deviation 12.77
Usual Clinical CareClinic Systolic Blood Pressure (mmHg)6 month132.50 mmHgStandard Deviation 15.83
Usual Clinical CareClinic Systolic Blood Pressure (mmHg)baseline137.97 mmHgStandard Deviation 14.33
Usual Clinical CareClinic Systolic Blood Pressure (mmHg)12 month130.7 mmHgStandard Deviation 15.22
Secondary

Amotivation as Assessed by the Treatment Self-Regulation Questionnaire for Diet

Amotivation measured at baseline, 6 months, and 12 months as assessed by the Treatment Self-Regulation Questionnaire (self-administration). This is a 15-item survey scored on a 7 point likert scale from 1 (not at all true) to 7 (very true). Mean score between 1 and 7 will be reported with higher scores indicative of increased amotivation.

Time frame: baseline, 6 month, and 12 month follow-up

Population: participants lost to follow up, withdrew, and/or removed from study per physician

ArmMeasureGroupValue (MEAN)Dispersion
InterventionAmotivation as Assessed by the Treatment Self-Regulation Questionnaire for Dietbaseline2.30 score on a scaleStandard Deviation 1.11
InterventionAmotivation as Assessed by the Treatment Self-Regulation Questionnaire for Diet6 months2.29 score on a scaleStandard Deviation 1.04
InterventionAmotivation as Assessed by the Treatment Self-Regulation Questionnaire for Diet12 months2.47 score on a scaleStandard Deviation 1.12
Usual Clinical CareAmotivation as Assessed by the Treatment Self-Regulation Questionnaire for Dietbaseline2.37 score on a scaleStandard Deviation 1.09
Usual Clinical CareAmotivation as Assessed by the Treatment Self-Regulation Questionnaire for Diet6 months2.45 score on a scaleStandard Deviation 1.16
Usual Clinical CareAmotivation as Assessed by the Treatment Self-Regulation Questionnaire for Diet12 months2.35 score on a scaleStandard Deviation 1.09
Secondary

Amotivation as Assessed by the Treatment Self-Regulation Questionnaire for Exercise

Amotivation measured at baseline, 6 months, and 12 months as assessed by the Treatment Self-Regulation Questionnaire (self-administration). This is a 15-item survey scored on a 7 point likert scale from 1 (not at all true) to 7 (very true). Mean score between 1 and 7 will be reported with higher scores indicative of increased amotivation.

Time frame: baseline, 6 month, and 12 month follow-up

Population: participants lost to follow up, withdrew, and/or removed from study per physician

ArmMeasureGroupValue (MEAN)Dispersion
InterventionAmotivation as Assessed by the Treatment Self-Regulation Questionnaire for Exercisebaseline2.27 score on a scaleStandard Deviation 1.09
InterventionAmotivation as Assessed by the Treatment Self-Regulation Questionnaire for Exercise6 months2.27 score on a scaleStandard Deviation 1.07
InterventionAmotivation as Assessed by the Treatment Self-Regulation Questionnaire for Exercise12 months2.55 score on a scaleStandard Deviation 1.17
Usual Clinical CareAmotivation as Assessed by the Treatment Self-Regulation Questionnaire for Exercise12 months2.34 score on a scaleStandard Deviation 1.08
Usual Clinical CareAmotivation as Assessed by the Treatment Self-Regulation Questionnaire for Exercisebaseline2.31 score on a scaleStandard Deviation 1.08
Usual Clinical CareAmotivation as Assessed by the Treatment Self-Regulation Questionnaire for Exercise6 months2.46 score on a scaleStandard Deviation 1.18
Secondary

Autonomous Motivation as Assessed by the Treatment Self-Regulation Questionnaire for Diet

Autonomous motivation measured at baseline, 6 months, and 12 months as assessed by the Treatment Self-Regulation Questionnaire (self-administration). This is a 15-item survey scored on a 7 point likert scale from 1 (not at all true) to 7 (very true). Mean score between 1 and 7 will be reported with higher scores indicative of increased autonomous motivation.

Time frame: baseline, 6 month, and 12 month follow-up

Population: participants lost to follow up, withdrew, and/or removed from study per physician

ArmMeasureGroupValue (MEAN)Dispersion
InterventionAutonomous Motivation as Assessed by the Treatment Self-Regulation Questionnaire for Dietbaseline5.80 score on a scaleStandard Deviation 1.02
InterventionAutonomous Motivation as Assessed by the Treatment Self-Regulation Questionnaire for Diet6 months5.86 score on a scaleStandard Deviation 1.02
InterventionAutonomous Motivation as Assessed by the Treatment Self-Regulation Questionnaire for Diet12 months5.78 score on a scaleStandard Deviation 1.02
Usual Clinical CareAutonomous Motivation as Assessed by the Treatment Self-Regulation Questionnaire for Dietbaseline5.80 score on a scaleStandard Deviation 1.06
Usual Clinical CareAutonomous Motivation as Assessed by the Treatment Self-Regulation Questionnaire for Diet6 months5.76 score on a scaleStandard Deviation 1.02
Usual Clinical CareAutonomous Motivation as Assessed by the Treatment Self-Regulation Questionnaire for Diet12 months5.85 score on a scaleStandard Deviation 0.95
Secondary

Autonomous Motivation as Assessed by the Treatment Self-Regulation Questionnaire for Exercise

Autonomous motivation measured at baseline, 6 months, and 12 months as assessed by the Treatment Self-Regulation Questionnaire (self-administration). This is a 15-item survey scored on a 7 point likert scale from 1 (not at all true) to 7 (very true). Mean score between 1 and 7 will be reported with higher scores indicative of increased autonomous motivation.

Time frame: baseline, 6 month, and 12 month follow-up

Population: participants lost to follow up, withdrew, and/or removed from study per physician

ArmMeasureGroupValue (MEAN)Dispersion
InterventionAutonomous Motivation as Assessed by the Treatment Self-Regulation Questionnaire for Exercisebaseline5.81 score on a scaleStandard Deviation 1.04
InterventionAutonomous Motivation as Assessed by the Treatment Self-Regulation Questionnaire for Exercise6 months5.94 score on a scaleStandard Deviation 1
InterventionAutonomous Motivation as Assessed by the Treatment Self-Regulation Questionnaire for Exercise12 months5.79 score on a scaleStandard Deviation 1.06
Usual Clinical CareAutonomous Motivation as Assessed by the Treatment Self-Regulation Questionnaire for Exercisebaseline5.81 score on a scaleStandard Deviation 1.07
Usual Clinical CareAutonomous Motivation as Assessed by the Treatment Self-Regulation Questionnaire for Exercise6 months5.74 score on a scaleStandard Deviation 1.03
Usual Clinical CareAutonomous Motivation as Assessed by the Treatment Self-Regulation Questionnaire for Exercise12 months5.83 score on a scaleStandard Deviation 1.04
Secondary

Controlled Motivation as Assessed by the Treatment Self-Regulation Questionnaire for Diet

Controlled motivation measured at baseline, 6 months, and 12 months as assessed by the Treatment Self-Regulation Questionnaire (self-administration). This is a 15-item survey scored on a 7 point likert scale from 1 (not at all true) to 7 (very true). Mean score between 1 and 7 will be reported with higher scores indicative of increased controlled motivation.

Time frame: baseline, 6 month, and 12 month follow-up

Population: participants lost to follow up, withdrew, and/or removed from study per physician

ArmMeasureGroupValue (MEAN)Dispersion
InterventionControlled Motivation as Assessed by the Treatment Self-Regulation Questionnaire for Dietbaseline3.19 score on a scaleStandard Deviation 1.25
InterventionControlled Motivation as Assessed by the Treatment Self-Regulation Questionnaire for Diet6 months3.30 score on a scaleStandard Deviation 1.09
InterventionControlled Motivation as Assessed by the Treatment Self-Regulation Questionnaire for Diet12 months3.36 score on a scaleStandard Deviation 1.11
Usual Clinical CareControlled Motivation as Assessed by the Treatment Self-Regulation Questionnaire for Dietbaseline3.04 score on a scaleStandard Deviation 1.23
Usual Clinical CareControlled Motivation as Assessed by the Treatment Self-Regulation Questionnaire for Diet6 months3.23 score on a scaleStandard Deviation 1.29
Usual Clinical CareControlled Motivation as Assessed by the Treatment Self-Regulation Questionnaire for Diet12 months3.39 score on a scaleStandard Deviation 1.31
Secondary

Controlled Motivation as Assessed by the Treatment Self-Regulation Questionnaire for Exercise

Controlled motivation measured at baseline, 6 months, and 12 months as assessed by the Treatment Self-Regulation Questionnaire (self-administration). This is a 15-item survey scored on a 7 point likert scale from 1 (not at all true) to 7 (very true). Mean score between 1 and 7 will be reported with higher scores indicative of increased controlled motivation.

Time frame: baseline, 6 month, and 12 month follow-up

Population: participants lost to follow up, withdrew, and/or removed from study per physician

ArmMeasureGroupValue (MEAN)Dispersion
InterventionControlled Motivation as Assessed by the Treatment Self-Regulation Questionnaire for Exercisebaseline3.20 score on a scaleStandard Deviation 1.23
InterventionControlled Motivation as Assessed by the Treatment Self-Regulation Questionnaire for Exercise6 months3.28 score on a scaleStandard Deviation 1.24
InterventionControlled Motivation as Assessed by the Treatment Self-Regulation Questionnaire for Exercise12 months3.17 score on a scaleStandard Deviation 1.16
Usual Clinical CareControlled Motivation as Assessed by the Treatment Self-Regulation Questionnaire for Exercisebaseline3.06 score on a scaleStandard Deviation 1.25
Usual Clinical CareControlled Motivation as Assessed by the Treatment Self-Regulation Questionnaire for Exercise6 months3.29 score on a scaleStandard Deviation 1.31
Usual Clinical CareControlled Motivation as Assessed by the Treatment Self-Regulation Questionnaire for Exercise12 months3.28 score on a scaleStandard Deviation 1.27
Secondary

Home Blood Pressure Monitoring Frequency

Self-report of home blood pressure monitoring frequency measured at baseline, 6 months, and 12 months.

Time frame: baseline, 6 month, and 12 month follow-up

Population: participants lost to follow up, withdrew, and/or removed from study per physician

ArmMeasureGroupCategoryValue (COUNT_OF_PARTICIPANTS)
InterventionHome Blood Pressure Monitoring FrequencyBaselineNot on a regular basis109 Participants
InterventionHome Blood Pressure Monitoring Frequency6 monthsAt least once a week64 Participants
InterventionHome Blood Pressure Monitoring FrequencyBaselineAt least once a day7 Participants
InterventionHome Blood Pressure Monitoring Frequency6 monthsAt least once a day13 Participants
InterventionHome Blood Pressure Monitoring FrequencyBaselineAt least once per month23 Participants
InterventionHome Blood Pressure Monitoring Frequency12 monthsNot on a regular basis32 Participants
InterventionHome Blood Pressure Monitoring Frequency6 monthsNot on a regular basis14 Participants
InterventionHome Blood Pressure Monitoring Frequency12 monthsAt least once per month20 Participants
InterventionHome Blood Pressure Monitoring FrequencyBaselineAt least once a week13 Participants
InterventionHome Blood Pressure Monitoring Frequency12 monthsAt least once a week30 Participants
InterventionHome Blood Pressure Monitoring Frequency6 monthsAt least once per month9 Participants
InterventionHome Blood Pressure Monitoring Frequency12 monthsAt least once a day4 Participants
Usual Clinical CareHome Blood Pressure Monitoring Frequency12 monthsAt least once a day4 Participants
Usual Clinical CareHome Blood Pressure Monitoring FrequencyBaselineNot on a regular basis118 Participants
Usual Clinical CareHome Blood Pressure Monitoring FrequencyBaselineAt least once per month20 Participants
Usual Clinical CareHome Blood Pressure Monitoring FrequencyBaselineAt least once a week17 Participants
Usual Clinical CareHome Blood Pressure Monitoring FrequencyBaselineAt least once a day4 Participants
Usual Clinical CareHome Blood Pressure Monitoring Frequency6 monthsNot on a regular basis67 Participants
Usual Clinical CareHome Blood Pressure Monitoring Frequency6 monthsAt least once per month22 Participants
Usual Clinical CareHome Blood Pressure Monitoring Frequency6 monthsAt least once a week10 Participants
Usual Clinical CareHome Blood Pressure Monitoring Frequency6 monthsAt least once a day5 Participants
Usual Clinical CareHome Blood Pressure Monitoring Frequency12 monthsNot on a regular basis67 Participants
Usual Clinical CareHome Blood Pressure Monitoring Frequency12 monthsAt least once per month11 Participants
Usual Clinical CareHome Blood Pressure Monitoring Frequency12 monthsAt least once a week8 Participants
Secondary

Number of Combined Fruit and Vegetable Servings as Assessed by the Automated Self-Administered 24-hour Dietary Assessment

Mean number of combined fruit and vegetable servings measured at baseline, 6 months, and 12 months as assessed by the computer administered Automated Self-Administered 24-hour Dietary Assessment, reported in cups equivalent.

Time frame: baseline, 6 month, and 12 month follow-up

Population: participants lost to follow up, withdrew, and/or removed from study per physician

ArmMeasureGroupValue (MEAN)Dispersion
InterventionNumber of Combined Fruit and Vegetable Servings as Assessed by the Automated Self-Administered 24-hour Dietary Assessmentbaseline2.34 cups per dayStandard Deviation 2.02
InterventionNumber of Combined Fruit and Vegetable Servings as Assessed by the Automated Self-Administered 24-hour Dietary Assessment6 months2.43 cups per dayStandard Deviation 1.75
InterventionNumber of Combined Fruit and Vegetable Servings as Assessed by the Automated Self-Administered 24-hour Dietary Assessment12 months2.50 cups per dayStandard Deviation 1.92
Usual Clinical CareNumber of Combined Fruit and Vegetable Servings as Assessed by the Automated Self-Administered 24-hour Dietary Assessmentbaseline2.50 cups per dayStandard Deviation 1.98
Usual Clinical CareNumber of Combined Fruit and Vegetable Servings as Assessed by the Automated Self-Administered 24-hour Dietary Assessment6 months2.57 cups per dayStandard Deviation 1.89
Usual Clinical CareNumber of Combined Fruit and Vegetable Servings as Assessed by the Automated Self-Administered 24-hour Dietary Assessment12 months2.55 cups per dayStandard Deviation 1.88
Secondary

Number of Participants That Achieve Hypertension Control at 6 Months

Hypertension Control: Percentage of participants that achieve hypertension control at 6 months. Hypertension control will be defined using ambulatory blood pressures as the gold standard (\<130/80 mmHg); otherwise a clinic blood pressure of \<140/90 mmHg will be used.

Time frame: up to 6 months

Population: participants lost to follow up, withdrew, and/or removed from study per physician, 2 participants in the Usual clinical care arm did not wear their cuff long enough to get adequate readings for AMBP

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
InterventionNumber of Participants That Achieve Hypertension Control at 6 Months24-hour Ambulatory Blood Pressure20 Participants
InterventionNumber of Participants That Achieve Hypertension Control at 6 MonthsClinic Measured Blood Pressure60 Participants
Usual Clinical CareNumber of Participants That Achieve Hypertension Control at 6 Months24-hour Ambulatory Blood Pressure21 Participants
Usual Clinical CareNumber of Participants That Achieve Hypertension Control at 6 MonthsClinic Measured Blood Pressure60 Participants
Secondary

Ounces of Whole Grain as Assessed by the Automated Self-Administered 24-hour Dietary Assessment

Ounces of whole grain measured at baseline, 6 months, and 12 months as assessed by the computer administered Automated Self-Administered 24-hour Dietary Assessment

Time frame: baseline, 6 month, and 12 month follow-up

Population: participants lost to follow up, withdrew, and/or removed from study per physician

ArmMeasureGroupValue (MEAN)Dispersion
InterventionOunces of Whole Grain as Assessed by the Automated Self-Administered 24-hour Dietary Assessmentbaseline0.61 ounces per dayStandard Deviation 1.05
InterventionOunces of Whole Grain as Assessed by the Automated Self-Administered 24-hour Dietary Assessment6 months0.88 ounces per dayStandard Deviation 1.49
InterventionOunces of Whole Grain as Assessed by the Automated Self-Administered 24-hour Dietary Assessment12 months0.82 ounces per dayStandard Deviation 1.25
Usual Clinical CareOunces of Whole Grain as Assessed by the Automated Self-Administered 24-hour Dietary Assessmentbaseline0.85 ounces per dayStandard Deviation 1.41
Usual Clinical CareOunces of Whole Grain as Assessed by the Automated Self-Administered 24-hour Dietary Assessment6 months1.12 ounces per dayStandard Deviation 1.62
Usual Clinical CareOunces of Whole Grain as Assessed by the Automated Self-Administered 24-hour Dietary Assessment12 months1.14 ounces per dayStandard Deviation 2.24
Secondary

Perceived Autonomy as Assessed by the Health Care Climate Questionnaire for Diet

Perceived autonomy measured at baseline, 6 months, and 12 months as assessed by the Health Care Climate Questionnaire (self-administration). This is a 6-item survey scored on a 7 point likert scale from 1 (not at all true) to 7 (very true). Mean between 1-7 will be reported with higher scores indicative of increased perceived autonomy.

Time frame: baseline, 6 month, and 12 month follow-up

Population: participants lost to follow up, withdrew, and/or removed from study per physician

ArmMeasureGroupValue (MEAN)Dispersion
InterventionPerceived Autonomy as Assessed by the Health Care Climate Questionnaire for Dietbaseline4.63 score on a scaleStandard Deviation 1.6
InterventionPerceived Autonomy as Assessed by the Health Care Climate Questionnaire for Diet6 months5.35 score on a scaleStandard Deviation 1.41
InterventionPerceived Autonomy as Assessed by the Health Care Climate Questionnaire for Diet12 months5.06 score on a scaleStandard Deviation 1.52
Usual Clinical CarePerceived Autonomy as Assessed by the Health Care Climate Questionnaire for Diet12 months5.22 score on a scaleStandard Deviation 1.4
Usual Clinical CarePerceived Autonomy as Assessed by the Health Care Climate Questionnaire for Dietbaseline4.93 score on a scaleStandard Deviation 1.58
Usual Clinical CarePerceived Autonomy as Assessed by the Health Care Climate Questionnaire for Diet6 months5.17 score on a scaleStandard Deviation 1.48
Secondary

Perceived Autonomy as Assessed by the Health Care Climate Questionnaire for Exercise

Perceived autonomy measured at baseline, 6 months, and 12 months as assessed by the Health Care Climate Questionnaire (self-administration). This is a 6-item survey scored on a 7 point likert scale from 1 (not at all true) to 7 (very true). Mean between 1-7 will be reported with higher scores indicative of increased perceived autonomy.

Time frame: baseline, 6 month, and 12 month follow-up

Population: participants lost to follow up, withdrew, and/or removed from study per physician

ArmMeasureGroupValue (MEAN)Dispersion
InterventionPerceived Autonomy as Assessed by the Health Care Climate Questionnaire for Exercisebaseline4.72 score on a scaleStandard Deviation 1.65
InterventionPerceived Autonomy as Assessed by the Health Care Climate Questionnaire for Exercise6 months5.31 score on a scaleStandard Deviation 1.38
InterventionPerceived Autonomy as Assessed by the Health Care Climate Questionnaire for Exercise12 months5.11 score on a scaleStandard Deviation 1.57
Usual Clinical CarePerceived Autonomy as Assessed by the Health Care Climate Questionnaire for Exercisebaseline5.00 score on a scaleStandard Deviation 1.53
Usual Clinical CarePerceived Autonomy as Assessed by the Health Care Climate Questionnaire for Exercise6 months5.17 score on a scaleStandard Deviation 1.5
Usual Clinical CarePerceived Autonomy as Assessed by the Health Care Climate Questionnaire for Exercise12 months5.31 score on a scaleStandard Deviation 1.4
Secondary

Perceived Competence as Assessed by the Perceived Competence Scale for Diet

Perceived competence measured at baseline, 6 months, and 12 months as assessed by the Perceived Competence Scale (self-administration). This is a 4-item survey scored on a 7 point likert scale from 1 (not at all true) to 7 (very true). Mean score from 1-7 will be reported with higher scores indicating increased perceived competence.

Time frame: baseline, 6 month, and 12 month follow-up

Population: participants lost to follow up, withdrew, and/or removed from study per physician

ArmMeasureGroupValue (MEAN)Dispersion
InterventionPerceived Competence as Assessed by the Perceived Competence Scale for DietBaseline4.54 score on a scaleStandard Deviation 1.34
InterventionPerceived Competence as Assessed by the Perceived Competence Scale for Diet6 months5.04 score on a scaleStandard Deviation 1.24
InterventionPerceived Competence as Assessed by the Perceived Competence Scale for Diet12 months4.71 score on a scaleStandard Deviation 1.25
Usual Clinical CarePerceived Competence as Assessed by the Perceived Competence Scale for DietBaseline4.56 score on a scaleStandard Deviation 1.3
Usual Clinical CarePerceived Competence as Assessed by the Perceived Competence Scale for Diet6 months4.63 score on a scaleStandard Deviation 1.43
Usual Clinical CarePerceived Competence as Assessed by the Perceived Competence Scale for Diet12 months4.70 score on a scaleStandard Deviation 1.3
Secondary

Perceived Competence as Assessed by the Perceived Competence Scale for Exercise

Perceived competence measured at baseline, 6 months, and 12 months as assessed by the Perceived Competence Scale (self-administration). This is a 4-item survey scored on a 7 point likert scale from 1 (not at all true) to 7 (very true). Mean score from 1-7 will be reported with higher scores indicating increased perceived competence.

Time frame: baseline, 6 month, and 12 month follow-up

Population: participants lost to follow up, withdrew, and/or removed from study per physician

ArmMeasureGroupValue (MEAN)Dispersion
InterventionPerceived Competence as Assessed by the Perceived Competence Scale for ExerciseBaseline4.83 score on a scaleStandard Deviation 1.45
InterventionPerceived Competence as Assessed by the Perceived Competence Scale for Exercise6 months5.28 score on a scaleStandard Deviation 1.37
InterventionPerceived Competence as Assessed by the Perceived Competence Scale for Exercise12 months4.98 score on a scaleStandard Deviation 1.47
Usual Clinical CarePerceived Competence as Assessed by the Perceived Competence Scale for ExerciseBaseline5.03 score on a scaleStandard Deviation 1.46
Usual Clinical CarePerceived Competence as Assessed by the Perceived Competence Scale for Exercise6 months5.01 score on a scaleStandard Deviation 1.54
Usual Clinical CarePerceived Competence as Assessed by the Perceived Competence Scale for Exercise12 months4.89 score on a scaleStandard Deviation 1.49
Secondary

Physical Activity as Assessed by the Godin Physical Activity Questionnaire

Mean weekly amounts of physical activity as assessed by the Godin Physical Activity Questionnaire. The Godin Physical Activity Questionnaire measures a person's strenuous, moderate, and light physical activity in a week. Scoring is calculated as follows (units are times per week that the participant engaged in any of the 3 classifications of activity longer than 15 minutes during their free time): * 9 x strenous units reported + 5 x moderate units reported + 3 x light units reported = score A minimum score of 0 indicates no activity, a score of less than 14 is interpreted as insufficiently active or sedentary, a score between 14 and 23 is interpreted to be moderately active, and a score of 24 and higher is interpreted to be active, a theoretical maximum does not exist.

Time frame: baseline, 6 month, and 12 month follow-up

Population: participants lost to follow up, withdrew, and/or removed from study per physician

ArmMeasureGroupValue (MEAN)Dispersion
InterventionPhysical Activity as Assessed by the Godin Physical Activity Questionnairebaseline38.24 score on a scaleStandard Deviation 31.51
InterventionPhysical Activity as Assessed by the Godin Physical Activity Questionnaire6 months54.47 score on a scaleStandard Deviation 61.99
InterventionPhysical Activity as Assessed by the Godin Physical Activity Questionnaire12 months46.67 score on a scaleStandard Deviation 46.1
Usual Clinical CarePhysical Activity as Assessed by the Godin Physical Activity Questionnairebaseline37.24 score on a scaleStandard Deviation 26.99
Usual Clinical CarePhysical Activity as Assessed by the Godin Physical Activity Questionnaire6 months40.69 score on a scaleStandard Deviation 31.8
Usual Clinical CarePhysical Activity as Assessed by the Godin Physical Activity Questionnaire12 months39.22 score on a scaleStandard Deviation 25.22
Secondary

Saturated Fat as Assessed by the Automated Self-Administered 24-hour Dietary Assessment

Saturated fat measured at baseline, 6 months, and 12 months as assessed by the computer administered Automated Self-Administered 24-hour Dietary Assessment, reported in percent kilocalories

Time frame: baseline, 6 month, and 12 month follow-up

Population: participants lost to follow up, withdrew, and/or removed from study per physician

ArmMeasureGroupValue (MEAN)Dispersion
InterventionSaturated Fat as Assessed by the Automated Self-Administered 24-hour Dietary Assessmentbaseline11.91 percent kilocaloriesStandard Deviation 4.19
InterventionSaturated Fat as Assessed by the Automated Self-Administered 24-hour Dietary Assessment6 months12.97 percent kilocaloriesStandard Deviation 4.62
InterventionSaturated Fat as Assessed by the Automated Self-Administered 24-hour Dietary Assessment12 months12.03 percent kilocaloriesStandard Deviation 4.72
Usual Clinical CareSaturated Fat as Assessed by the Automated Self-Administered 24-hour Dietary Assessmentbaseline12.54 percent kilocaloriesStandard Deviation 4.32
Usual Clinical CareSaturated Fat as Assessed by the Automated Self-Administered 24-hour Dietary Assessment6 months13.12 percent kilocaloriesStandard Deviation 6.56
Usual Clinical CareSaturated Fat as Assessed by the Automated Self-Administered 24-hour Dietary Assessment12 months13.46 percent kilocaloriesStandard Deviation 4.52
Secondary

Sodium Intake as Assessed by the Automated Self-Administered 24-hour Dietary Assessment

Mean daily sodium intake (milligrams/day) at baseline, 6 months, and 12 months as assessed by the computer administered Automated Self-Administered 24-hour Dietary Assessment

Time frame: baseline, 6 month, and 12 month follow-up

Population: participants lost to follow up, withdrew, and/or removed from study per physician

ArmMeasureGroupValue (MEAN)Dispersion
InterventionSodium Intake as Assessed by the Automated Self-Administered 24-hour Dietary Assessmentbaseline3512.82 milligrams per dayStandard Deviation 1765.59
InterventionSodium Intake as Assessed by the Automated Self-Administered 24-hour Dietary Assessment6 months3354.72 milligrams per dayStandard Deviation 1365.75
InterventionSodium Intake as Assessed by the Automated Self-Administered 24-hour Dietary Assessment12 months3682.94 milligrams per dayStandard Deviation 1874.53
Usual Clinical CareSodium Intake as Assessed by the Automated Self-Administered 24-hour Dietary Assessmentbaseline3672.81 milligrams per dayStandard Deviation 1812.82
Usual Clinical CareSodium Intake as Assessed by the Automated Self-Administered 24-hour Dietary Assessment6 months3968.20 milligrams per dayStandard Deviation 1725.17
Usual Clinical CareSodium Intake as Assessed by the Automated Self-Administered 24-hour Dietary Assessment12 months4213.67 milligrams per dayStandard Deviation 1972.37
Secondary

Standing Weight (kg)

Weight (kg) measured at baseline, 6 months, and 12 months.

Time frame: baseline, 6 month, and 12 month follow-up

Population: participants lost to follow up, withdrew, and/or removed from study per physician

ArmMeasureGroupValue (MEAN)Dispersion
InterventionStanding Weight (kg)12 months97.91 kilogramsStandard Deviation 26.07
InterventionStanding Weight (kg)6 months98.54 kilogramsStandard Deviation 26.19
InterventionStanding Weight (kg)baseline102.86 kilogramsStandard Deviation 28.64
Usual Clinical CareStanding Weight (kg)6 months103.80 kilogramsStandard Deviation 25.34
Usual Clinical CareStanding Weight (kg)12 months103.45 kilogramsStandard Deviation 25.49
Usual Clinical CareStanding Weight (kg)baseline102.93 kilogramsStandard Deviation 27.3
Other Pre-specified

Adverse Events

Number and type of adverse events

Time frame: Through study completion, an average of 5 years

Other Pre-specified

Health Coach Fidelity to the Study Intervention

Evaluation of health coach fidelity to administering the motivational interviewing intervention per protocol will be assessed every 2 months using a modified Behavior Change Counseling Index

Time frame: through completion of administering the study intervention, an average of 4 years

Other Pre-specified

Serious Adverse Events

Number and type of serious adverse events

Time frame: Through study completion, an average of 5 years

Other Pre-specified

Withdrawal

Subject Withdrawal Rate

Time frame: Through study completion, an average of 5 years

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026